Insider trades
Terrie Curran, Director of Arcutis Biotherapeutics ARQT, has filed 1 purchase and 6 sales on the open market. The latest trade was on 06/05.
Terrie Curran
Director
- Company
- Arcutis Biotherapeutics ARQT
- First filing
- 23/01/20
- Trades
- 31 trades
- Buys / sales
- 1 / 6
- 12-month net buying
- No record
- Last trade
- 06/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/01/21 | 25/01/23 | 19,109 sh | $6.59 | $125,928.31 | −5.0% | |
| Open-market sale | 24/11/11 | 24/11/13 | 8,687 sh | $10.85 | $94,253.95 | −46.1% | |
| Open-market sale | 24/07/15 | 24/07/17 | 33,848 sh | $11.72 | $396,698.56 | −8.2% | |
| Open-market sale | 24/03/22 | 24/03/26 | 16,851 sh | $9.11 | $153,512.61 | −3.9% | |
| Open-market buy | 23/04/06 | 23/04/07 | 12,919 sh | $7.82 | $101,026.58 | +7.4% | |
| Open-market sale | 23/03/01 | 23/03/03 | 1,436 sh | $8.54 | $12,263.44 | −0.8% | |
| Open-market sale | 23/01/20 | 23/01/20 | 5,821 sh | $8.20 | $47,732.2 | −3.2% |
